Evaluation of plasma and tissue estrogen suppression with third-generation aromatase inhibitors: Of relevance to clinical understanding?
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference77 articles.
1. Aminoglutethimide (Elipten-Ciba) is an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial;Cash;J. Clin. Endocrinol. Metab.,1967
2. Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma;Santen;Ann. Intern. Med.,1982
3. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma;Samojlik;J. Clin. Invest.,1980
4. Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma;Santen;J. Clin. Endocrinol. Metab.,1978
5. The effect of an aromatase inhibitor, 4-hydroxy-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer;Brodie;Endocrinology,1977
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane;Breast Cancer Research and Treatment;2024-04-23
2. Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation;npj Breast Cancer;2024-01-18
3. Changes in serum estrogenic activity during neoadjuvant therapy with letrozole and exemestane;The Journal of Steroid Biochemistry and Molecular Biology;2020-06
4. Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial;Breast Cancer Research;2020-05-14
5. Treatment of Metastatic Breast Cancer: Endocrine Therapy;Breast Disease;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3